GH peptides · research peptide
Ipamorelin
Selective GHS-R agonist used in GH pulse and metabolic signalling research.
≥98.7% purity by third-party HPLC · White lyophilized powder · Certificate of Analysis with every order
| 5 mg vial | $44.99 · monthly $40.49 |
|---|---|
| 10 mg vial | $80.99 · monthly $72.89 |
| 15 mg vial | $111.99 · monthly $100.79 |
Specifications
| Purity (HPLC, third party) | ≥98.7% |
|---|---|
| Molecular weight | 711.85 g/mol |
| Appearance | White lyophilized powder |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| PubChem record | CID 9831659 |
| Category | GH peptides |
Research background
Ipamorelin is a pentapeptide growth hormone secretagogue and selective ghrelin receptor (GHS-R1a) agonist. It is notable in research for its high selectivity — studies suggest it stimulates GH release without significantly affecting cortisol, prolactin, or ACTH levels at typical research concentrations.
Its compact five amino acid structure and high receptor selectivity have made it a valuable pharmacological tool in metabolic and neuroendocrine research, particularly for studying the pulsatile regulation of the GH axis in cell and tissue models.
References
- Raun K. et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol.
- Johansen P.B. et al. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Research.
Storage and handling
For laboratory research use only. Not for human or veterinary use. Sold to researchers aged 18 or older.